Arqt stock price - The transaction was executed at a price of $5.87 per share, resulting in a 0.08% impact on the firm's portfolio. This acquisition has increased the firm's stake in Arcutis Biotherapeutics to 5.20%. Find the latest Arcutis Biotherapeutics, Inc. (ARQT) stock quote, history, news and other vital information to help you with your stock trading and ...

 
Use our equities screener to discover other potential opportunities. Find Similar Stocks Find Stocks Similar to ARQT ... Share price information may be rounded up .... How to download apps on roku tv

Arcutis Biotherapeutics Inc (ARQT) stock is trading at $6.98 as of 10:27 AM on Wednesday, Feb 14, an increase of $0.08, or 1.16% from the previous closing price of $6.90. The stock has traded between $6.92 and $7.50 so far today. Volume today is less active than usual.ARQT stock closed at $6.06 and is down -$0.06 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARQT has a roughly average overall score of 56 meaning the stock holds a better value than 56% of stocks at its current price.Turning out attention to how the Arcutis Biotherapeutics Inc stock has performed in comparison to its peers in the industry, here’s what we find: ARQT’s stock is 6.19% on the day and -76.49% in the past 12 months, while Eli Lilly & Co. (LLY) traded 1.59%% in the last session and was positioned 61.87% up on its price 12 months ago.Arcutis Biotherapeutics. Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and ... Buy or Sell Consensus Earnings Calendar Exposure. ARQT Stock. USD 5.30 0.46 9.50%. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Arcutis BiotherapeuticsInc is 'Strong Hold'. Macroaxis provides Arcutis BiotherapeuticsI buy-hold-or-sell recommendation only in the context of selected ...Arcutis Biotherapeutics (ARQT) (Delayed Data from NSDQ) $9.30 USD +1.33 (16.69%) Updated Feb 16, 2024 04:00 PM ET After-Market: $9.27 -0.03 (-0.32%) 7:58 …Arcutis Biotherapeutics Inc stock price live 9.68, this page displays NASDAQ ARQT stock exchange data. View the ARQT premarket stock price ahead of the market session or assess the after hours quote.Jun 28, 2023 ... Related Stocks. ARQT. 5.76. 0.05 (0.79%). 02:49:35 PM. Arcutis ... stock. price target chart. This current average has decreased by 11.34 ...Current. -$0.80. 1 Month Ago. -$0.84. 3 Months Ago. -$0.84. Arcutis Biotherapeutics Inc. analyst estimates, including ARQT earnings per share estimates and analyst recommendations.3 days ago · With Arcutis Biotherapeutics stock trading at $5.30 per share, the total value of Arcutis Biotherapeutics stock (market capitalization) is $500.22M. Arcutis Biotherapeutics stock was originally listed at a price of $21.80 in Jan 31, 2020. If you had invested in Arcutis Biotherapeutics stock at $21.80, your return over the last 3 years would ... The 6 analysts offering 1 year price forecasts for ARQT have a max estimate of — and a min estimate of —. Analyst rating Based on 7 analysts giving stock ratings to ARQT in the past 3 months. Feb 14, 2024 ... As of February 14, 2024, 4:00 PM, CST, Arcutis Biotherapeutics Inc's stock price was $7.58. Arcutis Biotherapeutics Inc is up 9.86% from its ...What is the target price for Arcutis Biotherapeutics (ARQT) stock? The latest price target for Arcutis Biotherapeutics ( NASDAQ: ARQT) was reported by Mizuho on Wednesday, January 3, 2024. The ...ARQT is the ticker symbol for Arcutis Biotherapeutics, Inc., a biotechnology company that develops and commercializes treatments for skin diseases. The web page shows the …According to our current ARQT stock forecast, the value of Arcutis Biotherapeutics shares will drop by -31.48% and reach $ 6.50 per share by February 26, 2024. According to our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear).ARQT stock recorded 22/30 (73%) green days with 30.53% price volatility …Arcutis Biotherapeutics, Inc. (ARQT) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. As of 10:08AM EST. Market open. See Arcutis Biotherapeutics, Inc. (ARQT) stock analyst estimates ... Discover historical prices for ARQT stock on Yahoo Finance. View daily, weekly or monthly format back to when Arcutis Biotherapeutics, Inc. stock was issued. Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...Arcutis (ARQT) is a good speculative biotech play. It has already received FDA approval of ZORYVE and it has a PDUFA date expected for the end of 2023. See more here.Real time Arcutis Biotherapeutics (ARQT) stock price quote, stock graph, news & analysis. ARQT Stock: Mixed Performance on October 13, 2023 with Positive Future Growth Potential. On October 13, 2023, ARQT stock experienced a mixed performance. The stock opened at $4.46, slightly lower than the previous day’s closing price of $4.51. Throughout the day, the stock’s price fluctuated between a low of $3.84 and a high of …Check out our ARQT stock analysis, current ARQT quote, charts, and historical prices for Arcutis Biotherapeutics Inc stock. ... Select Price, Percent change, or Dollar change as the y-axis.A US$407m market cap addition is just what Arqit Quantum Inc. (NASDAQ:ARQQ) insiders like to see after purchasing stock worth UK£72m. (Simply Wall St.) Oct-04-21 08:27AM. Arqit Founders Voluntarily Extend Lock-up. (Business Wire) +13.44%. Sep-15-21 08:25AM. Arqit and Juniper Networks Sign Technology Alliance Partner Connect Agreement ...Lexicon Pharmaceutcl. $2.47 $-0.18 (-6.79%) Thinking about buying or selling stock in ARQT? See the latest Arcutis Biotherapeutics Inc (ARQT) stock analysis, price, forecast, news and more.ARQT stock closed at $3.64 and is up $0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARQT has a roughly average overall score of 42 meaning the stock holds a better value than 42% of stocks at its current price.Arcutis Biotherapeutics Inc Stock (ARQT) is expected to reach an average price of $14.13 in 2025, with a high prediction of $23.70 and a low estimate of $4.5648 ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...The transaction was executed at a price of $5.87 per share, resulting in a 0.08% impact on the firm's portfolio. This acquisition has increased the firm's stake in Arcutis Biotherapeutics to 5.20% ... The transaction was executed at a price of $5.87 per share, resulting in a 0.08% impact on the firm's portfolio. This acquisition has increased the firm's stake in Arcutis Biotherapeutics to 5.20% ... Arcutis Biotherapeutics Inc stock price (ARQT) NASDAQ: ARQT. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Arcutis Biotherapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.ARQT | Complete Arcutis Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. What is the Arcutis Biotherapeutics stock forecast? The Arcutis Biotherapeutics stock forecast for tomorrow is $ 9.08, which would represent a -5.62% loss ...Arcutis Biotherapeuticsinc Stock Buy Hold or Sell Recommendation. Buy or Sell Consensus Earnings Calendar Exposure. ARQT Stock. USD 5.30 0.46 9.50%. Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Arcutis BiotherapeuticsInc is 'Strong Hold'. Macroaxis provides Arcutis BiotherapeuticsI ...The average one-year price target for Arcutis Biotherapeutics (NasdaqGS:ARQT) has been revised to 13.60 / share. This is an increase of 11.11% from the prior estimate of 12.24 …Arcutis Biotherapeutics GAAP EPS of -$1.27 beats by $0.22. SA NewsThu, May 05, 2022. 2 3. Get the latest news and real-time alerts from Arcutis Biotherapeutics, Inc. (ARQT) stock at Seeking Alpha.Get the latest Arcutis Biotherapeutics, Inc. (ARQT) stock news and headlines to help you in your trading and investing decisions. Summary of all time highs, changes and price drops for Arcutis Biotherapeutics; Historical stock prices; Current Share Price: US$9.30: 52 Week High: US$17.57Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...3 days ago · What is the target price for Arcutis Biotherapeutics (ARQT) stock? The latest price target for Arcutis Biotherapeutics ( NASDAQ: ARQT) was reported by Mizuho on Wednesday, January 3, 2024. The ... Find out all the key statistics for Arcutis Biotherapeutics, Inc. (ARQT), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Chg %. $9.48. 0.18. 1.94%. Arcutis Biotherapeutics Inc. advanced stock charts by MarketWatch. View ARQT historial stock data and compare to other stocks and exchanges.ARQT delivered a four-quarter earnings surprise of 9.23%, on average. In the past 60 days, estimates for Puma Biotechnology’s 2024 earnings per share have …Sep 22, 2023 ... As of September 22, 2023, 4:00 PM, CST, Arcutis Biotherapeutics Inc's stock price was $5.38. Arcutis Biotherapeutics Inc is down 5.78% from its ...The latest price target for . Arcutis Biotherapeutics (NASDAQ: ARQT) was reported by Mizuho on January 3, 2024.The analyst firm set a price target for $8.00 expecting ARQT to fall to within 12 ... Real time Arcutis Biotherapeutics (ARQT) stock price quote, stock graph, news & analysis.ARQT stock closed at $3.64 and is up $0.08 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARQT has a roughly average overall score of 42 meaning the stock holds a better value than 42% of stocks at its current price.Arcutis Biotherapeutics. Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and ...ARQT stock closed at $6.06 and is down -$0.06 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARQT has a roughly average overall score of 56 meaning the stock holds a better value than 56% of stocks at its current price.The stock, despite an approval, is down 85% since that time, so it seems my reluctance was justified. However, the price at the time was around $18, and the highest price point it reached, it ...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll wan...3 days ago · Arcutis Biotherapeutics, Inc. is a medical dermatology company. The Company is focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its portfolio is comprised of topi. Latest Arcutis Biotherapeutics Inc (ARQT:NSQ) share price with interactive charts, historical prices, comparative ... 3 days ago · Based on short-term price targets offered by six analysts, the average price target for Arcutis Biotherapeutics, Inc. comes to $15.17. The forecasts range from a low of $6.00 to a high of $38.00 ... Lexicon Pharmaceutcl. $2.47 $-0.18 (-6.79%) Thinking about buying or selling stock in ARQT? See the latest Arcutis Biotherapeutics Inc (ARQT) stock analysis, price, forecast, news and more.This would represent a -20.41% increase in the ARQT stock price. Arcutis Biotherapeutics Stock Prediction 2030. In 2030, the Arcutis Biotherapeutics stock will reach $ 2.34 if it maintains its current 10-year average growth rate. If this Arcutis Biotherapeutics stock prediction for 2030 materializes, ARQT stock willgrow -74.58% from its current ... Chg %. $9.48. 0.18. 1.94%. Arcutis Biotherapeutics Inc. advanced stock charts by MarketWatch. View ARQT historial stock data and compare to other stocks and exchanges.The latest price target for . Arcutis Biotherapeutics (NASDAQ: ARQT) was reported by Mizuho on January 3, 2024.The analyst firm set a price target for $8.00 expecting ARQT to fall to within 12 ... Dec 29, 2023 ... TRADING UPSIDE STARTED : ARQT STOCK ANALYSIS | ARCUTIS BIOTHERAPEUTICS STOCK ... Price Action Trading like a Pro - I share my best tips after 14 ...5 days ago ... Latest ARQT News along with Price and Volume Analysis ARQT Stock Analysis $ARQT Latest News TickerDD. No views · 50 minutes ago ...more ...Arcutis Biotherapeutics Inc stock price live 9.68, this page displays NASDAQ ARQT stock exchange data. View the ARQT premarket stock price ahead of the market session or assess the after hours quote.79.13 -0.06(-0.08%) Gold 2,026.80 +2.70(+0.13%) Arcutis Biotherapeutics, Inc. (ARQT) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 9.30 …Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may...The value each ARQT share was expected to gain vs. the value that each ARQT share actually gained.. Arcutis Biotherapeutics (ARQT) reported Q3 2023 earnings per share (EPS) of-$0.73, beating estimates of -$0.91 by 20.63%.In the same quarter last year, Arcutis Biotherapeutics's earnings per share (EPS) was-$1.89.Arcutis Biotherapeutics is …Complete Arcutis Biotherapeutics Inc. stock information by Barron's. View real-time ARQT stock price and news, along with industry-best analysis. The average twelve-month price prediction for Arcutis Biotherapeutics is $25.11 with a high price target of $50.00 and a low price target of $6.00. Learn more ...Stock Price Statistics The stock price has decreased by -39.08% in the last 52 weeks. The beta is 0.97, so ARQT's price volatility has been similar to the market average.View Arcutis Biotherapeutics Inc ARQT stock quote prices, financial information, real-time forecasts, and company news from CNN.Arcutis Biotherapeutics, Inc. (ARQT Quick Quote ARQT - Free Report) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily ...5,005.57 –0.48% Nasdaq 15,775.65 –0.82% Crude Oil 79.20 +0.01% Euro 1.08 +0.41% Dow Jones 38,627.99 –0.37% Russell 2000Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...The stock, despite an approval, is down 85% since that time, so it seems my reluctance was justified. However, the price at the time was around $18, and the highest price point it reached, it ...66.61%. Get the latest Arcutis Biotherapeutics Inc (ARQT) real-time quote, historical performance, charts, and other financial information to help you make more informed …3 days agoArcutis Biotherapeutics GAAP EPS of -$1.27 beats by $0.22. SA NewsThu, May 05, 2022. 2 3. Get the latest news and real-time alerts from Arcutis Biotherapeutics, Inc. (ARQT) stock at Seeking Alpha.Statistics. The Arcutis Biotherapeutics, Inc. stock price is closed at $ 2.96 with a total market cap valuation of $ 279.37M (94.38M shares outstanding). The Arcutis Biotherapeutics, Inc. is trading on NASDAQ with the sign ARQT.Arcutis Biotherapeutics, Inc. price is up 13.85% in the past 24 hours. The Arcutis Biotherapeutics, Inc. stock price …ARQT stock closed at $3.30 and is up $0.15 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARQT has a roughly average overall score of 38 meaning the stock holds a better value than 38% of stocks at its current price.The transaction was executed at a price of $5.87 per share, resulting in a 0.08% impact on the firm's portfolio. This acquisition has increased the firm's stake in Arcutis Biotherapeutics to 5.20%. Find the latest Arcutis Biotherapeutics, Inc. (ARQT) stock quote, history, news and other vital information to help you with your stock trading and ...View real-time Arcutis Biotherapeutics Inc (ARQT) share prices and assess historical data, ... Use the dropdown to select a relevant stock exchange for the current NASDAQ ARQT share price (ISIN: US03969K1088) to enhance your trading decisions with our free resources. Day's Range. 8.93 9.51. 52 wk Range.Arcutis Biotherapeutics Inc (ARQT) $3.25 0.02 (0.61%) 16:00 EST ARQT Stock Quote Delayed 30 Minutes.LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, has received ISO/IEC 27001 certification for information security and cybersecurity protection. Recognised as the world’s best-known standard for data security, ISO/IEC 27001 conformity demonstrates Arqit’s ...In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according ...ARQT Stock Performance on November 6, 2023. ARQT, a health technology company operating in the pharmaceuticals industry, experienced an eventful day in the stock market on November 6, 2023. The stock’s previous close was $2.22, but it opened at $2.43. Throughout the day, the stock’s price fluctuated between a low of $2.38 and a …Arcutis Biotherapeutics. Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and ... The latest closing stock price for Arcutis Biotherapeutics as of January 11, 2024 is 3.70. The all-time high Arcutis Biotherapeutics stock closing price was 36.98 on February 08, 2021. The Arcutis Biotherapeutics 52-week high stock price is 17.57, which is 374.9% above the current share price. The Arcutis Biotherapeutics 52-week low stock price ...Summary of all time highs, changes and price drops for Arcutis Biotherapeutics; Historical stock prices; Current Share Price: US$9.30: 52 Week High: US$17.57Arcutis Biotherapeutics (NASDAQ:ARQT) Third Quarter 2023 ResultsKey Financial Results. Revenue: US$38.1m (up by US$37.4m from 3Q 2022). Net loss: US$44.8m (loss narrowed by 58% from 3Q 2022).3 days agoView real-time Arcutis Biotherapeutics Inc (ARQT) share prices and assess historical data, ... Use the dropdown to select a relevant stock exchange for the current NASDAQ ARQT share price (ISIN: US03969K1088) to enhance your trading decisions with our free resources. Day's Range. 8.93 9.51. 52 wk Range.Feb 19, 2024Jan 30, 2024 ... Arcutis Biotherapeutics Inc Stock Prediction and Forecast [ARQT] Arcutis Biotherapeutics Inc price prediction was made for Wednesday, ...ARQT stock closed at $2.96 and is up $0.11 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ARQT has a roughly average overall score of 37 meaning the stock holds a better value than 37% of stocks at its current price.

ARQT | stock. $9.68. 0.62%. $895 M. 0.00%. $0.00-Overview - ARQT. Overview. Ratings. Recommendation. Payouts. Div Growth. Capture Strategy. News & Research. Profile. Home Dividend Stocks Health Care Biotech Pharma Large Pharma ARCUTIS BIOTHERAPEUTICS, INC. ... Days Taken For Stock Price To Recover. Target check balance gift card

arqt stock price

JonesTrading analyst Sean Kim PhD has maintained their neutral stance on ARQT stock, giving a Hold rating today. ... Goldman Sachs also maintained a Hold rating on the stock with a $6.00 price target.Discover historical prices for ARQT stock on Yahoo Finance. View daily, weekly or monthly format back to when Arcutis Biotherapeutics, Inc. stock was issued. Chg %. $9.48. 0.18. 1.94%. Arcutis Biotherapeutics Inc. advanced stock charts by MarketWatch. View ARQT historial stock data and compare to other stocks and exchanges.Aug 11, 2023 ... (NASDAQ:ARQT) Price Target To US$41.57. Simply Wall St ... Adaptimmune Therapeutics plc (NASDAQ:ADAP) Stock Catapults 107% Though Its Price And ...Their ARQT share price targets range from $6.00 to $50.00. On average, they predict the company's share price to reach $24.22 in the next year. This suggests a …Arcutis (ARQT) is a good speculative biotech play. It has already received FDA approval of ZORYVE and it has a PDUFA date expected for the end of 2023. See more here.Turning out attention to how the Arcutis Biotherapeutics Inc stock has performed in comparison to its peers in the industry, here’s what we find: ARQT’s stock is 6.19% on the day and -76.49% in the past 12 months, while Eli Lilly & Co. (LLY) traded 1.59%% in the last session and was positioned 61.87% up on its price 12 months ago.ARQT - Arcutis Biotherapeutics Inc - Stock screener for investors and traders, financial visualizations.WESTLAKE VILLAGE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an aggregate of 33,750 restricted stock units of Arcutis’ common stock to five …Arcutis Biotherapeutics Consensus Analyst Rating and Stock Price Forecast (2024) Analysts' Consensus Rating Moderate Buy Based on 9 Analyst Ratings Analysts' …Feb 19, 2024 · ARQT is a biotechnology company developing treatments for immune-mediated dermatological diseases. It has a quantitative rating of 1-star and a price/fair value ratio of 34% as of Feb 9, 2024. If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Arcutis Biotherapeutics, Inc. (ARQT) stock forecast and price target. Find the latest Arcutis Biotherapeutics, Inc. ARQT analyst stock forecast, price target, and recommendation trends with in ...ARQT support price is $6.09 and resistance is $7.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARQT stock will trade within this expected range on the day. View a ... In the last 3 months, 7 analysts have offered 12-month price targets for Arcutis Biotherapeutics. The company has an average price target of $38.14 with a high of $57.00 and a low of $22.00..

Popular Topics